NEW YORK, June 28 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Global Acute Coronary Syndrome industry
http://www.reportlinker.com/p0197235/Global-Acute-Coronary-Syndrome-industry.html
This report analyzes the global market for Acute Coronary
Syndrome Therapeutics in US$ Million. Annual estimates and
forecasts are provided for the period 2006 through 2015. The report
profiles 60 companies including Abbott Laboratories Inc.,
AstraZeneca, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers
Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s
Laboratories Ltd., Eli Lilly and Company, F. Hoffmann-La Roche
Ltd., GlaxoSmithKline plc, Inverness Medical Innovations, Inc.,
Merck & Co., Inc., Medicure Inc., Novartis AG, Pfizer, Inc.,
Wyeth, Sanofi-Aventis SA, Schering-Plough Corp., Siemens Healthcare
Diagnostics, Inc., Takeda Pharmaceutical Company Limited, and The
Medicines Company. Market data and analytics are derived from
primary and secondary research. Company profiles are mostly
extracted from URL research and reported select online sources.
ACUTE CORONARY SYNDROME MCP-635
‘/>”/>
